Current and Emerging Technology for Continuous Glucose Monitoring
AbstractDiabetes has become a leading cause of death worldwide. Although there is no cure for diabetes, blood glucose monitoring combined with appropriate medication can enhance treatment efficiency, alleviate the symptoms, as well as diminish the complications. For point-of-care purposes, continuous glucose monitoring (CGM) devices are considered to be the best candidates for diabetes therapy. This review focuses on current growth areas of CGM technologies, specifically focusing on subcutaneous implantable electrochemical glucose sensors. The superiority of CGM systems is introduced firstly, and then the strategies for fabrication of minimally-invasive and non-invasive CGM biosensors are discussed, respectively. Finally, we briefly outline the current status and future perspective for CGM systems. View Full-Text
Share & Cite This Article
Chen, C.; Zhao, X.-L.; Li, Z.-H.; Zhu, Z.-G.; Qian, S.-H.; Flewitt, A.J. Current and Emerging Technology for Continuous Glucose Monitoring. Sensors 2017, 17, 182.
Chen C, Zhao X-L, Li Z-H, Zhu Z-G, Qian S-H, Flewitt AJ. Current and Emerging Technology for Continuous Glucose Monitoring. Sensors. 2017; 17(1):182.Chicago/Turabian Style
Chen, Cheng; Zhao, Xue-Ling; Li, Zhan-Hong; Zhu, Zhi-Gang; Qian, Shao-Hong; Flewitt, Andrew J. 2017. "Current and Emerging Technology for Continuous Glucose Monitoring." Sensors 17, no. 1: 182.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.